Workflow
同源康医药-B建议采纳2025年H股激励计划
TYK MEDICINESTYK MEDICINES(HK:02410) Zhi Tong Cai Jing·2025-10-14 14:56

Core Viewpoint - The company, Tongyuan Kangyi Yao-B (02410), has proposed to adopt the 2025 H-share incentive plan, indicating a strategic move to enhance employee motivation and align their interests with shareholders [1] Group 1 - The board of directors has recommended the implementation of the 2025 H-share incentive plan [1]